Cancer Communications (Mar 2023)
C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data
Abstract
No abstracts available.
Cancer Communications (Mar 2023)